Company intelligence / Profile preview

Kibow Therapeutics

Newtown Square, Pennsylvania, United Stateskibowtx.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Kibow Therapeutics’ lead candidate KT-301/US‑APR2020—a live biotherapeutic consortium of proprietary commensal bacteria—has entered Phase 2b clinical trials in patients with stage 4 CKD. The goal is to validate safety and efficacy in delaying dialysis and improving kidney function by reducing uremic toxins through gut microbiome modulation. About half of the targeted enrollment has been achieved as of recent updates. Preclinical and early clinical data support safety and positive outcomes for renal health; additional studies are planned for ESRD/dialysis populations

Therapeutic areas: Nephrology
Modalities: Live biotherapeutic product therapyMicrobial therapyProbiotic supplement
Industry: Biotech

Drug pipeline

2 assets

KT-301

1 more asset in the full pipeline.

Request access →

Partnerships

No major pharmaceutical partnerships disclosed; received SBIR grants from NIDDK-NIH and USAID funding for R&D

Beyond the preview

Go deeper on Kibow Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kibow Therapeutics.

Explore the full profile